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Central to the research enterprise is the application of
scientific methods appropriate to achieving the investi-
gational aims. In the case of controlled clinical trials,
assay sensitivity is achieved through careful selection of
study sample, design, and assessment instruments.
Treatments and controls must be precisely defined and
quantified. Concomitant interventions need to be speci-
fied and delimited. The actual implementation of the
protocol requires procedures for ensuring fidelity, con-
sistency, and reproducibility. Typically, a clinical trial
protocol is the result of contributions from experts in
clinical care, experimental methodology, bioethics, sta-
tistics, and data management.
Appreciating the research methodology of a study is
critical for understanding the value and the limitations
of the results. The quality of methods is especially
important in the case of so called “negative” trials, as
are often called studies that, though designed to reject a
null hypothesis of equivalence, do not find significant
differences between treatments. Distinguishing a truly
negative trial (i.e., a study indicating that no difference
between treatments actually exists) from a “failed trial”
(i.e., a study that lacks assay sensitivity and is unable to
detect a difference even if it exists) depends primarily
on the strength of the research methodology of the trial.
While considerable effort usually goes into preparing
the methods for a controlled clinical trial, only a fraction
of this work is actually mentioned in the publication of
the results. There are several reasons for this situation.
First, space limitations prevent a detailed description of
the methodology and a critical discussion of the theore-
tical and practical reasons for the choices that were
made vis-à-vis the possible alternatives. Second, though
the interpretation of the results hinges on a thorough
understanding of the methods that were used, many
readers of scientific literature would not have the time
of entering into these details. Lastly, in order to appreci-
ate the methodological structure behind a research
study, one needs to have some basic expertise in it,
something that not all the consumers of clinical research
actually have.
However, a more detailed sharing of clinical trial
methods than is commonly done in the typical publica-
tion of the study results is valuable from a number of
perspectives. Researchers reading their colleagues’ work
can have the opportunity of appreciating the elements
of the study and understanding the rationale for choos-
ing a particular design and specific measurements. Even
if all clinical trials share a common experimental basis,
there can be also considerable innovation underway, at
the level of design, sample selection, measurement tools,
bioethical assessment, and statistical analyses [1,2]. It is
fair to say that, regardless of any standardization of
design, treatments and assessment tools, many clinical
trials have unique features regarding their methods and/
or their implementation. More detailed descriptions of
study methods and critical discussions of their strengths
and limitations can foster the development of more sen-
sitive, valid, efficient, and ultimately informative clinical
research. Finally, publishing the study methodology
separately and in advance of the results papers offers
the authors the practical benefit of being able to refer
the readers to a detailed description of the study back-
ground when reporting the results.
In recent years, a movement towards publishing
design and methods considerations separately from the
result reports has occurred both in adult and child psy-
chiatry [3-6]. The report by Compton et al., published
in CAPMH this month, outlines the rationale, design,
and methods of the Child/Adolescent Anxiety Multimo-
dal Study (CAMS) [7], and provides another example of
how this type of papers can help us better understand
and appreciate the results of clinical trials. Along these
lines, CAPMH welcomes the submission of similar
manuscripts describing and discussing the methodologi-
cal aspects of clinical trials in child and adolescent men-
tal health.
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